suPARnostic® Approval in India

Wed Jun 06 2018

suPARnostic® Approval in India

The suPARnostic® product has been approved by the Central Drugs Standard Control Organisation, New Delhi, and given permission to import, for which Form 10 license was issued in May 2017.

Congratulations to our distributor Super Biotech Pvt Ltd, who already has trials of the suPARnostic® product running at several hospitals in India.

Super Biotech Pvt Ltd has added a new phone number +91 11 45073677 specially for suPAR inquiries in India.

Contact information to Super Biotech – please see here


published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex


For Automated Systems

Photo of suPARnostic® ELISA


Clinical and Research

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates